scispace - formally typeset
Open AccessJournal ArticleDOI

Genetic Analysis of DNA Excreted in Urine: A New Approach for Detecting Specific Genomic DNA Sequences from Cells Dying in an Organism

TLDR
The data suggest that the kidney barrier in rodents and humans is permeable to DNA molecules large enough to be analyzed by standard genetic methodologies.
Abstract
Background: Cell-free DNA from dying cells recently has been discovered in human blood plasma. In experiments performed on animals and humans, we examined whether this cell-free DNA can cross the kidney barrier and be used as a diagnostic tool. Methods: Mice received subcutaneous injections of either human Raji cells or purified 32P-labeled DNA. DNA was isolated from urine and analyzed by measurement of radioactivity, agarose gel electrophoresis, and PCR. In humans, the permeability of the kidney barrier to polymeric DNA was assessed by detection in urine of sequences that were different from an organism bulk nuclear DNA. Results: In the experiments on laboratory animals, we found that ∼0.06% of injected DNA was excreted into urine within 3 days in a polymeric form and that human-specific Alu sequences that passed through the kidneys could be amplified by PCR. In humans, male-specific sequences could be detected in the urine of females who had been transfused with male blood as well as in DNA isolated from urine of women pregnant with male fetuses. K- ras mutations were detected in the urine of patients with colon adenocarcinomas and pancreatic carcinomas. Conclusions: The data suggest that the kidney barrier in rodents and humans is permeable to DNA molecules large enough to be analyzed by standard genetic methodologies.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Liquid biopsies come of age: towards implementation of circulating tumour DNA

TL;DR: The field is now in an exciting transitional period in which ctDNA analysis is beginning to be applied clinically, although there is still much to learn about the biology of cell-free DNA.
Journal ArticleDOI

Integrating liquid biopsies into the management of cancer

TL;DR: How different forms of liquid biopsies can be exploited to guide patient care and should ultimately be integrated into clinical practice is examined, focusing on liquid biopsy of ctDNA — arguably the most clinically advanced approach.
Journal ArticleDOI

Circulating nucleic acids (CNAs) and cancer--a survey.

TL;DR: In the past few years many experiments showed that tumor-associated alterations can be detected at the DNA and RNA level, and laid the foundation for the development of assays for an early detection of cancer as well as for other clinical means.
Journal ArticleDOI

Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules

TL;DR: This Review summarizes advances from the past 5 years in the development of electrochemical sensors for clinically relevant biomolecules, including small molecules, nucleic acids, and proteins and addresses the remaining challenges and opportunities.
Journal ArticleDOI

High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity

TL;DR: High‐mobility group box 1 protein (HMGB1), a nuclear protein that is released passively when necrotic cells lose the integrity of their membranes, acts in an autocrine/paracrine fashion and sustains long‐term repair and defense programs.
References
More filters
Book

Molecular Cloning: A Laboratory Manual

TL;DR: Molecular Cloning has served as the foundation of technical expertise in labs worldwide for 30 years as mentioned in this paper and has been so popular, or so influential, that no other manual has been more widely used and influential.
Journal ArticleDOI

A simple, rapid, and sensitive DNA assay procedure.

TL;DR: The dissociation of chromatin is critical to accurate determinations of DNA in biological materials using this method, which can detect as little as 10 ng of DNA with rather unsophisticated instrumentation.
Journal ArticleDOI

Presence of fetal DNA in maternal plasma and serum

TL;DR: The finding of circulating fetal DNA in maternal plasma may have implications for non-invasive prenatal diagnosis, and for improving the understanding of the fetomaternal relationship.
Journal ArticleDOI

Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis

TL;DR: In this paper, a real-time quantitative PCR assay was developed to measure the concentration of fetal DNA in maternal plasma and serum, and the results showed that fetal DNA is present in high concentrations in maternal placenta, reaching a mean of 25.4 genome equivalents/ml (range 3.3-69.4) in early pregnancy and 292.2 genome equivalents /ml(range 76.9-769) in late pregnancy.
Journal Article

Free DNA in the Serum of Cancer Patients and the Effect of Therapy

TL;DR: The relatively high percentage of cancer patients with apparently normal DNA levels would suggest that this radioimmunoassay may have low diagnostic value, but DNA in the serum may be an important tool for the evaluation of therapy or the comparison of different regimens.
Related Papers (5)